Announcement on a Wholly-owned Subsidiary Obtaining One Drug Registration Certificate
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on a Wholly-owned Subsidiary Obtaining One Drug Registration Certificate
Filed with SSE · · 2 pages · Chinese
On 6ix: 6ix.com/news/announcement-on-a-wholly-owned-subsidiary-obtaining-one-drug-registration-certificate
Release
Yabao Pharmaceutical Group Co. Ltd. on 6ix
Earlier from Yabao Pharmaceutical
- Announcement on Convening the Q3 2024 Performance Briefing
- Announcement on Correction of Report for Q3 2024
- Report for Q3 2024
- Announcement on Obtaining Approval of Phase II Clinical Trial for New Indication of Project SY-009
- Announcement on Notice to Creditors
Later from Yabao Pharmaceutical
- Announcement on the Termination of the Technology Transfer Agreement for the Traditional Chinese Medicine New Drug Project
- Announcement on the Repurchased Company Shares Reaching 1% and Repurchase Progress
- Announcement on ZY-A001 Obtaining Notice of Approval for Drug Clinical Trials
- Announcement on Implementation Results of Share Repurchase and Share Changes
- Announcement on Release of Pledge of Some Shares of Controlling Shareholder
Follow Yabao Pharmaceutical into a list and get an email when it puts out news.
Follow Yabao Pharmaceutical